In Vivo Analysis of the Biocompatibility and Immune Response of Jellyfish Collagen Scaffolds and its Suitability for Bone Regeneration
READ POSTThe £1.9m round, which was 75% funded by international investors, will enable Jellagen to develop and partner pipeline products aimed at tissue reconstruction, diabetic wound care management and rare skin diseases.
READ POSTJellagen was shown to have an increased level of synchronisation when compared against Matrigel
READ POSTDiscover why collagen is such an important component for successful cell culture
READ POSTGregg replaces Stephane Thiroloix who will remain as a non-executive director at Jellagen®.
READ POSTFind the full list of conferences the Jellagen team will attend throughout 2020
READ POSTFrontiers Journal in Bioengineering and Biotechnology titled ‘Marine Collagen Substrates for 2D and 3D Ovarian Cancer Cell Systems’
READ POSTCo-culture of Astrocytes and Cortical Neurons
READ POSTAdipose-derived stem cells
READ POSTJellagen® launches their first purified jellyfish collagen hydrogel: JellaGel™
READ POST© 2020 Jellagen. All rights reserved. Company Registration No. SC451036
